Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4123)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 15, 2024 (publication date) through Apr 1, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Li HY, Jing YM, Shen X, Tang MY, Shen HH, Li XW, Wang ZS, Su F. Protein tyrosine phosphatase non-receptor II: A possible biomarker of poor prognosis and mediator of immune evasion in hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(9): 3913-3931 [PMID: 39350977 DOI: 10.4251/wjgo.v16.i9.3913] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Li HY, Jing YM, Shen X, Tang MY, Shen HH, Li XW, Wang ZS, Su F. Protein tyrosine phosphatase non-receptor II: A possible biomarker of poor prognosis and mediator of immune evasion in hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(9): 3913-3931 [PMID: 39350977 DOI: 10.4251/wjgo.v16.i9.3913] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i9/3913.htm |
| Number | Citing Articles |
| 1 |
Mingkang Yu, Di Yang, Xiuli Chen, Yuling Yang, Bingqiang Zhang, Xinxin Jiang, Lijie Xing, Yuxuan Yang, Yani Sun, Ning Li. Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. Molecular Biomedicine 2026; 7(1) doi: 10.1186/s43556-026-00427-2
|
| 2 |
Tony Tiganis, Nicholas K. Tonks. Mechanisms, functions and therapeutic targeting of protein tyrosine phosphatases. Nature Reviews Molecular Cell Biology 2026; 27(2): 129 doi: 10.1038/s41580-025-00882-9
|
| 3 |
Mo-Wei Kong, Yang Yu, Ying Wan, Yu Gao, Chun-Xiang Zhang. From biomarker discovery to combined therapies: Advancing hepatocellular carcinoma treatment strategies. World Journal of Gastrointestinal Oncology 2024; 16(11): 4518-4521 doi: 10.4251/wjgo.v16.i11.4518
|
| 4 |
Ozlem Ceren Gunizi, Gulsum Ozlem Elpek. Protein tyrosine phosphatase nonreceptor 2: A New biomarker for digestive tract cancers. World Journal of Gastrointestinal Oncology 2025; 17(2): 100546 doi: 10.4251/wjgo.v17.i2.100546
|